|
![]() |
|
|
Ceftriaxone: profile and news
American Pharma Gets Ceftriaxone FDA OK Feb 16, 2006 American Pharmaceutical Partners Receives Two FDA Approvals for ... Feb 16, 2006 American Pharmaceutical Partners Receives Two FDA Approvals for ... Feb 16, 2006 Buy Orchid Chemicals; growth unfolding: Edelweiss Sec Feb 26, 2006 Getting healthier Feb 19, 2006 MSF leads a campaign to vaccinate 100,000 people in southern ... Feb 19, 2006 Extraintestinal Salmonella Infection Appearing as a Suspicious ... Feb 9, 2006 (PRN) - Focus Media to Announce Fourth Quarter and Full Year 2005 ... Feb 16, 2006 Article presents epidemiology of typhoid fever in Mauritius Feb 16, 2006 Record year for Roche's pharma unit Feb 1, 2006 Other information Indication For the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph Pharmacology Ceftriaxone is a cephalosporin/cephamycin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. Ceftriaxone has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Ceftriaxone results from the inhibition of cell wall synthesis and is mediated through Ceftriaxone binding to penicillin binding proteins (PBPs). Ceftriaxone is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. Mechanism Of Action Ceftriaxone works by inhibiting the mucopeptide synthesis in the bacterial cell wall. The beta-lactam moiety of Ceftriaxone binds to carboxypeptidases, endopeptidases, and transpeptidases in the bacterial cytoplasmic membrane. These enzymes are involved in cell-wall synthesis and cell division. By binding to these enzymes, Ceftriaxone results in the formation of of defective cell walls and cell death. Drug Category Anti-bacterial Agents; Cephalosporins; ATC:J01DD04 Brand Names/Synonyms Biotrakson; Cefatriaxone; Ceftriaxona [Inn-Spanish]; Ceftriaxone; Ceftriaxone [Usan:Jan]; Ceftriaxone and Dextrose in Duplex Container; Ceftriaxonum [Inn-Latin]; Ceftriazone; DRG-0071; Rocephin; Rocephine Dosage Forms Dosage_Forms:IV Infusion; Absorption Not Available Interactions Interactions for Ceftriaxone: No information provided. Chemical IUPAC Name 8-[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino-4-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid Chemical Formula C18H18N8O7S3 Half Life 5.8-8.7 hours Drug Type Approved Drug # Accession No APRD00395 CAS Registry Number 73384-59-5 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |